5. Conclusion
Benzydamine HCl as oromucosal spray 0.3% and 3 mg lozenges confirmed its value providing a rapid relief from symptoms of ST with a high safety profile and product acceptability, thus representing a valuable tool in the clinical practice for the treatment of ST, allowing the patients to choose between 2 equivalent benzydamine HCl formulations according to their own preferences.